147 related articles for article (PubMed ID: 23136030)
1. Podocytes proliferate: novel mechanism identified in collapsing glomerulopathies.
Zhu C; Mertens PR
Int Urol Nephrol; 2013 Feb; 45(1):275-9. PubMed ID: 23136030
[No Abstract] [Full Text] [Related]
2. Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling.
Shkreli M; Sarin KY; Pech MF; Papeta N; Chang W; Brockman SA; Cheung P; Lee E; Kuhnert F; Olson JL; Kuo CJ; Gharavi AG; D'Agati VD; Artandi SE
Nat Med; 2011 Dec; 18(1):111-9. PubMed ID: 22138751
[TBL] [Abstract][Full Text] [Related]
3. For better or worse: a niche for Notch in parietal epithelial cell activation.
Sweetwyne MT; Susztak K
Kidney Int; 2013 Jun; 83(6):988-90. PubMed ID: 23728000
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of nonimmune glomerulopathies.
Kwoh C; Shannon MB; Miner JH; Shaw A
Annu Rev Pathol; 2006; 1():349-74. PubMed ID: 18039119
[TBL] [Abstract][Full Text] [Related]
5. Telomerase at the center of collapsing glomerulopathy.
Chugh SS; Clement LC
Nat Med; 2012 Jan; 18(1):26-7. PubMed ID: 22227662
[TBL] [Abstract][Full Text] [Related]
6. Repair problems in podocytes: Wnt, Notch, and glomerulosclerosis.
Kato H; Susztak K
Semin Nephrol; 2012 Jul; 32(4):350-6. PubMed ID: 22958489
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta1 reduces Wilms' tumor suppressor gene expression in podocytes.
Sakairi T; Abe Y; Kopp JB
Nephrol Dial Transplant; 2011 Sep; 26(9):2746-52. PubMed ID: 21378152
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease.
Lee HS
Cell Tissue Res; 2012 Jan; 347(1):129-40. PubMed ID: 21541658
[TBL] [Abstract][Full Text] [Related]
9. Alpha-actinin-4 and CLP36 protein deficiencies contribute to podocyte defects in multiple human glomerulopathies.
Liu Z; Blattner SM; Tu Y; Tisherman R; Wang JH; Rastaldi MP; Kretzler M; Wu C
J Biol Chem; 2011 Sep; 286(35):30795-30805. PubMed ID: 21680739
[TBL] [Abstract][Full Text] [Related]
10. Focal and segmental glomerulosclerosis: multiple pathways are involved.
Meyrier A
Semin Nephrol; 2011 Jul; 31(4):326-32. PubMed ID: 21839365
[TBL] [Abstract][Full Text] [Related]
11. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
Pol J Pathol; 2006; 57(1):17-21. PubMed ID: 16739878
[TBL] [Abstract][Full Text] [Related]
12. Genetic podocyte lineage reveals progressive podocytopenia with parietal cell hyperplasia in a murine model of cellular/collapsing focal segmental glomerulosclerosis.
Suzuki T; Matsusaka T; Nakayama M; Asano T; Watanabe T; Ichikawa I; Nagata M
Am J Pathol; 2009 May; 174(5):1675-82. PubMed ID: 19359523
[TBL] [Abstract][Full Text] [Related]
13. Podocytes: a new player for glutamate signaling.
Armelloni S; Li M; Messa P; Rastaldi MP
Int J Biochem Cell Biol; 2012 Dec; 44(12):2272-7. PubMed ID: 23018105
[TBL] [Abstract][Full Text] [Related]
14. The renin-angiotensin system in glomerular podocytes: mediator of glomerulosclerosis and link to hypertensive nephropathy.
Durvasula RV; Shankland SJ
Curr Hypertens Rep; 2006 May; 8(2):132-8. PubMed ID: 16672146
[TBL] [Abstract][Full Text] [Related]
15. Parietal epithelial cells and podocytes in glomerular diseases.
Smeets B; Moeller MJ
Semin Nephrol; 2012 Jul; 32(4):357-67. PubMed ID: 22958490
[TBL] [Abstract][Full Text] [Related]
16. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
[TBL] [Abstract][Full Text] [Related]
17. Glomerular homeostasis requires a match between podocyte mass and metabolic load.
Kopp JB
J Am Soc Nephrol; 2012 Aug; 23(8):1273-5. PubMed ID: 22797185
[No Abstract] [Full Text] [Related]
18. Soluble urokinase receptor and focal segmental glomerulosclerosis.
Reiser J; Wei C; Tumlin J
Curr Opin Nephrol Hypertens; 2012 Jul; 21(4):428-32. PubMed ID: 22569341
[TBL] [Abstract][Full Text] [Related]
19. Effects of TGF-beta on podocyte growth and disease progression in proliferative podocytopathies.
Lee HS; Song CY
Kidney Blood Press Res; 2010; 33(1):24-9. PubMed ID: 20185928
[TBL] [Abstract][Full Text] [Related]
20. Partial podocyte replenishment in experimental FSGS derives from nonpodocyte sources.
Kaverina NV; Eng DG; Schneider RR; Pippin JW; Shankland SJ
Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1397-413. PubMed ID: 27076646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
